share_log

Tenax Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.42) Estimate

Benzinga ·  Mar 25 20:09

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.42) by 57.14 percent. This is a 98.48 percent increase over losses of $(11.84) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 367

Recommended

Write a comment